Yang Dong

3.3k total citations
89 papers, 2.0k citations indexed

About

Yang Dong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yang Dong has authored 89 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Yang Dong's work include Sarcoma Diagnosis and Treatment (13 papers), Bone Tumor Diagnosis and Treatments (10 papers) and MicroRNA in disease regulation (8 papers). Yang Dong is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Bone Tumor Diagnosis and Treatments (10 papers) and MicroRNA in disease regulation (8 papers). Yang Dong collaborates with scholars based in China, United States and Australia. Yang Dong's co-authors include Zhou Songyang, Hyeung Kim, Quanyuan He, Xinglian Xu, Yuanyan Xiong, Ying Fan, Jiejun Wen, Niansong Wang, Hao Fu and Yongjie Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biomaterials.

In The Last Decade

Yang Dong

86 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Dong China 27 1.1k 426 293 225 218 89 2.0k
Xiaorui Han China 26 934 0.9× 542 1.3× 144 0.5× 163 0.7× 128 0.6× 72 2.0k
Aria Masoudifar Iran 17 1.4k 1.3× 781 1.8× 165 0.6× 427 1.9× 213 1.0× 20 2.3k
Lin Tang China 26 1.4k 1.2× 679 1.6× 94 0.3× 336 1.5× 337 1.5× 142 2.4k
Wenxin Song United States 17 1.1k 1.0× 285 0.7× 161 0.5× 216 1.0× 270 1.2× 35 1.8k
Xiaoyan Wu China 28 1.3k 1.2× 529 1.2× 179 0.6× 365 1.6× 128 0.6× 66 2.1k
Zhen Huang China 27 1.2k 1.1× 541 1.3× 351 1.2× 671 3.0× 424 1.9× 73 2.5k
Chunhong Jia China 26 1.2k 1.1× 440 1.0× 103 0.4× 215 1.0× 341 1.6× 57 2.1k
Yong Shi China 23 971 0.9× 301 0.7× 100 0.3× 305 1.4× 170 0.8× 64 1.7k
Yi He China 25 707 0.6× 181 0.4× 120 0.4× 486 2.2× 187 0.9× 88 1.9k

Countries citing papers authored by Yang Dong

Since Specialization
Citations

This map shows the geographic impact of Yang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Dong more than expected).

Fields of papers citing papers by Yang Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Dong. The network helps show where Yang Dong may publish in the future.

Co-authorship network of co-authors of Yang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Dong. A scholar is included among the top collaborators of Yang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Dong. Yang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jie, Zhiqiang Liu, Ni Ding, et al.. (2025). 67P: A phase II study of sunvozertinib combined with anlotinib in EGFR-TKIs resistant EGFRm advanced NSCLC patients (WUKONG9). Journal of Thoracic Oncology. 20(3). S52–S52. 1 indexed citations
2.
Wang, Xinlei, et al.. (2025). Unveiling ammonia-induced cell death: a new frontier in clear cell renal cell carcinoma prognosis. Frontiers in Immunology. 16. 1636977–1636977. 1 indexed citations
3.
Luo, Meifeng, et al.. (2024). How does emission allowance allocation affect shipowners’ selection of emission reduction technologies?. Transportation Research Part D Transport and Environment. 139. 104573–104573. 5 indexed citations
4.
Hu, Junyi, Kai Ji, Shengpeng Jiang, et al.. (2023). CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells. Cell Reports Medicine. 4(8). 101151–101151. 32 indexed citations
5.
Guo, Jingjing, Yang Dong, Bao Zhang, et al.. (2023). The safety of Pfannenstiel incision for specimen extraction in laparoscopic colorectal surgery for colorectal cancer: a systematic review and meta-analysis. Videosurgery and Other Miniinvasive Techniques. 19(1). 1–10. 2 indexed citations
6.
Zhang, Yiming, et al.. (2023). Molecular features and predictive models identify the most lethal subtype and a therapeutic target for osteosarcoma. Frontiers in Oncology. 13. 1111570–1111570. 3 indexed citations
7.
Ni, Yizhao, Yan Zhang, Hui Tian, et al.. (2023). EP07.02-01 Evaluation of the Efficacy of Oral Bacterial Lysates in Patients with High-risk Lung Nodules Detected by CT Screening. Journal of Thoracic Oncology. 18(11). S523–S523. 1 indexed citations
8.
Zhang, Zhichang, Weiping Ji, Jin Huang, et al.. (2022). Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. Clinical and Translational Medicine. 12(11). e1072–e1072. 25 indexed citations
9.
10.
Li, Xiaomei, Jiejun Wen, Yang Dong, et al.. (2021). Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling. Cell Death and Disease. 12(1). 92–92. 34 indexed citations
11.
Dong, Yang, et al.. (2021). Alpha-(1,6)-fucosyltransferase (FUT8) affects the survival strategy of osteosarcoma by remodeling TNF/NF-κB2 signaling. Cell Death and Disease. 12(12). 1124–1124. 17 indexed citations
12.
Gong, Ke, Yang Dong, Liting Wang, et al.. (2020). <p>Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma</p>. International Journal of Nanomedicine. Volume 15. 5561–5571. 10 indexed citations
13.
Zhang, Yanhua, Yang Dong, Hao Fu, et al.. (2020). Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance. Biomaterials. 269. 120478–120478. 44 indexed citations
14.
Dong, Yang, et al.. (2020). microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis. Journal of Experimental & Clinical Cancer Research. 39(1). 201–201. 23 indexed citations
15.
Fan, Lin, Yang Dong, Kaiyuan Liu, et al.. (2019). The comparison of gap balance technique and measured resection technique in total knee arthroplasty. Zhonghua guke zazhi. 39(15). 935–943. 1 indexed citations
16.
Wang, Feng, Jinghua Han, Li Wang, et al.. (2017). CCCTC-Binding Factor Transcriptionally Targets Wdr5 to Mediate Somatic Cell Reprogramming. Stem Cells and Development. 26(10). 743–750. 11 indexed citations
17.
Qin, Shu, et al.. (2016). Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor. Orthopaedic Surgery. 8(2). 212–219. 6 indexed citations
18.
Zhang, Jianjun, Huijuan Dai, Jianquan Hou, et al.. (2015). Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury. Journal of the American Society of Nephrology. 27(1). 92–106. 49 indexed citations
19.
Xu, Zhonghua, Yang Dong, Fang Peng, et al.. (2015). Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice. Cancer Gene Therapy. 22(4). 181–187. 8 indexed citations
20.
Dong, Yang, Yuanyan Xiong, Hyeung Kim, et al.. (2011). Human telomeric proteins occupy selective interstitial sites. Cell Research. 21(7). 1013–1027. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaorui Han Breakdown of academic impact, for papers by Aria Masoudifar Breakdown of academic impact, for papers by Lin Tang Breakdown of academic impact, for papers by Wenxin Song Breakdown of academic impact, for papers by Xiaoyan Wu Breakdown of academic impact, for papers by Zhen Huang Breakdown of academic impact, for papers by Chunhong Jia Breakdown of academic impact, for papers by Yong Shi Breakdown of academic impact, for papers by Yi He
Rankless by CCL
2026